| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8672109 | Journal of Vascular Surgery | 2018 | 10 Pages |
Abstract
Current data and reimbursements support the use of DCB as a cost-effective strategy for endovascular intervention in the SFA; any additional effectiveness of DES comes at a high price. Use of more than one DCB per intervention significantly decreases cost-effectiveness.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Natalie D. MD, MS, Aureline MD, Kenneth MD, MS, Kathy Noorbakhsh, Efthymios MD, PhD, Mohammad H. MD, Michel MD, Rabih MD, MS,